HVEM Peptide
| Code | Size | Price |
|---|
| PSI-45-753P-0.1mg | 0.1mg | £404.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Target Species: Human
Application: Blocking
Storage:
-20°C
Documents
Further Information
Additional Names:
TR2, ATAR, HVEA, HVEM, CD270, LIGHTR, UNQ329/PRO509, Tumor necrosis factor receptor superfamily member 14, Herpes virus entry mediator A, Herpesvirus entry mediator A
Application Note:
HVEM Peptide is used for blocking the activity of HVEM antibody (catalog number 45-753). The HVEM antibody ships at 0.5 mg/mL and the HVEM Peptide ships as a 100 ug pellet. When peptide is reconstituted in 200 uL water, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
Buffer:
HVEM peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 μL water, the concentration will be 0.5 mg/mL.
NCBI Gene ID #:
8764
NCBI Official Name:
tumor necrosis factor receptor superfamily, member 14
NCBI Official Symbol:
TNFRSF14
NCBI Organism:
Homo sapiens
Peptide aa Location:
HVEM peptide corresponds to 12 amino acids of HVEM.
Physical State:
Lyophilized
Protein Accession #:
NP_003811.2
Protein GI Number:
23200041
Swissprot #:
Q92956